SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
iRobot Corporation (IRBT) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+120270.4%).
- Analyst consensus target $65.00 (+120270.4% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 34/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IRBT
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-4.92
Book Value / Share$0.00
Revenue / Share$23.04
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$65.00 (+120270.4%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$1.47 |
$616.78M |
$44.13M |
7.2% |
| 2016 |
$1.48 |
$660.6M |
$41.94M |
6.3% |
| 2017 |
$1.77 |
$883.91M |
$50.96M |
5.8% |
| 2018 |
$3.07 |
$1.09B |
$87.99M |
8.1% |
| 2019 |
$2.97 |
$1.21B |
$85.3M |
7% |
| 2020 |
$5.14 |
$1.43B |
$147.07M |
10.3% |
| 2021 |
$1.08 |
$1.56B |
$30.39M |
1.9% |
| 2022 |
$-10.52 |
$1.18B |
$-286.3M |
-24.2% |
| 2023 |
$-11.01 |
$890.58M |
$-304.71M |
-34.2% |
| 2024 |
$-4.92 |
$681.85M |
$-145.52M |
-21.3% |
